Literature DB >> 33584669

Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.

Nannan Yang1, Kristin Lode2, Rodrigo Berzaghi2, Ashraful Islam2, Inigo Martinez-Zubiaurre2, Turid Hellevik3.   

Abstract

Recent studies have demonstrated that radiotherapy is able to induce anti-tumor immune responses in addition to mediating direct cytotoxic effects. Cancer-associated fibroblasts (CAFs) are central constituents of the tumor stroma and participate actively in tumor immunoregulation. However, the capacity of CAFs to influence immune responses in the context of radiotherapy is still poorly understood. This study was undertaken to determine whether ionizing radiation alters the CAF-mediated immunoregulatory effects on natural killer (NK) cells. CAFs were isolated from freshly resected non-small cell lung cancer tissues, while NK cells were prepared from peripheral blood of healthy donors. Functional assays to study NK cell immune activation included proliferation rates, expression of cell surface markers, secretion of immunomodulators, cytotoxic assays, as well as production of intracellular activation markers such as perforin and granzyme B. Our data show that CAFs inhibit NK cell activation by reducing their proliferation rates, the cytotoxic capacity, the extent of degranulation, and the surface expression of stimulatory receptors, while concomitantly enhancing surface expression of inhibitory receptors. Radiation delivered as single high-dose or in fractioned regimens did not reverse the immunosuppressive features exerted by CAFs over NK cells in vitro, despite triggering enhanced surface expression of several checkpoint ligands on irradiated CAFs. In summary, CAFs mediate noticeable immune inhibitory effects on cytokine-activated NK cells during co-culture in a donor-independent manner. However, ionizing radiation does not interfere with the CAF-mediated immunosuppressive effects.
Copyright © 2021 Yang, Lode, Berzaghi, Islam, Martinez-Zubiaurre and Hellevik.

Entities:  

Keywords:  TME; cancer-associated fibroblasts; immune evasion; immunosuppression; immunotherapy; ionizing radiation; radiotherapy; tumor microenvironment

Mesh:

Year:  2021        PMID: 33584669      PMCID: PMC7874190          DOI: 10.3389/fimmu.2020.602530

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  58 in total

Review 1.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

2.  Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma.

Authors:  Sophia Platonova; Julien Cherfils-Vicini; Diane Damotte; Lucile Crozet; Vincent Vieillard; Pierre Validire; Pascale André; Marie-Caroline Dieu-Nosjean; Marco Alifano; Jean-François Régnard; Wolf-Herman Fridman; Catherine Sautès-Fridman; Isabelle Cremer
Journal:  Cancer Res       Date:  2011-06-27       Impact factor: 12.701

Review 3.  NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends.

Authors:  Jules Russick; Carine Torset; Edouard Hemery; Isabelle Cremer
Journal:  Semin Immunol       Date:  2020-09-06       Impact factor: 11.130

Review 4.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 5.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

6.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.

Authors:  François Ghiringhelli; Cédric Ménard; Magali Terme; Caroline Flament; Julien Taieb; Nathalie Chaput; Pierre E Puig; Sophie Novault; Bernard Escudier; Eric Vivier; Axel Lecesne; Caroline Robert; Jean-Yves Blay; Jacky Bernard; Sophie Caillat-Zucman; Antonio Freitas; Thomas Tursz; Orianne Wagner-Ballon; Claude Capron; William Vainchencker; François Martin; Laurence Zitvogel
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

7.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

8.  Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition.

Authors:  Branca I Pereira; Oliver P Devine; Milica Vukmanovic-Stejic; Emma S Chambers; Priya Subramanian; Neil Patel; Alex Virasami; Neil J Sebire; Veronica Kinsler; Alexis Valdovinos; Claude Jourdan LeSaux; João F Passos; Antony Antoniou; Malcom H A Rustin; Judith Campisi; Arne N Akbar
Journal:  Nat Commun       Date:  2019-06-03       Impact factor: 14.919

9.  Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2.

Authors:  Chung Hee Sonn; Jong Rip Choi; Tae-Jin Kim; Young-Bin Yu; Kwanghee Kim; Suk Chul Shin; Gil-Hong Park; Toshiro Shirakawa; Hee Sun Kim; Kyung-Mi Lee
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

Review 10.  The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells.

Authors:  Cristina Cerboni; Cinzia Fionda; Alessandra Soriani; Alessandra Zingoni; Margherita Doria; Marco Cippitelli; Angela Santoni
Journal:  Front Immunol       Date:  2014-01-07       Impact factor: 7.561

View more
  6 in total

1.  Meaningful connections: Interrogating the role of physical fibroblast cell-cell communication in cancer.

Authors:  Jaye C Gardiner; Edna Cukierman
Journal:  Adv Cancer Res       Date:  2022-02-24       Impact factor: 5.767

2.  Potential of Gold Nanoparticle in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblast Cells.

Authors:  Abdulaziz Alhussan; Nicholas Palmerley; Julian Smazynski; Joanna Karasinska; Daniel J Renouf; David F Schaeffer; Wayne Beckham; Abraham S Alexander; Devika B Chithrani
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

3.  Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.

Authors:  Ruoyao Zou; Qidi Jiang; Tianqiang Jin; Mo Chen; Liangqing Yao; Hongda Ding
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 4.  Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy.

Authors:  Raisa A Glabman; Peter L Choyke; Noriko Sato
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

Review 5.  Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.

Authors:  Kit Yee Wong; Alvin Ho-Kwan Cheung; Bonan Chen; Wai Nok Chan; Jun Yu; Kwok Wai Lo; Wei Kang; Ka Fai To
Journal:  Int J Cancer       Date:  2022-06-08       Impact factor: 7.316

Review 6.  Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment.

Authors:  Tiecheng Wang; Jiakang Jin; Chao Qian; Jianan Lou; Jinti Lin; Ankai Xu; Kaishun Xia; Libin Jin; Bing Liu; Huimin Tao; Zhengming Yang; Wei Yu
Journal:  Cancer Cell Int       Date:  2021-06-07       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.